Month: April 2022

SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced the acceptance of two abstracts presenting preclinical data on its systemic therapeutics delivery system for presentation at the Controlled Release Society (CRS) 2022 Annual Meeting. CRS is an international gathering of experts in the design, development, and implementation of novel drug delivery technologies. This year’s meeting is focused on advanced delivery science and will take place in Montreal, Canada, July 11-15, 2022. Details of the presentations are as follows:Abstract Title: Development of ex-vivo and in-vivo models to assess the performance of an oral biotherapeutic delivery system capsule. (3732683)Presenting...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. MONTREAL, April 06, 2022 (GLOBE NEWSWIRE) — MONARCH MINING CORPORATION (“Monarch” or the “Corporation”) (TSX: GBAR) (OTCQX: GBARF) is pleased to announce that it has closed its previously announced private placement for aggregate gross proceeds of C$14,400,000 (the “Offering”). The Offering was conducted on a “best efforts” private placement basis pursuant to the terms and conditions of an agency agreement entered into among the Corporation, and Stifel GMP and Sprott Capital Partners LP, as co-lead agents and joint bookrunners (collectively, the “Co-Lead Agents”), and Desjardins Securities Inc. and Laurentian Bank Securities Inc. (together with the Co-Lead Agents, the “Agents”). The Offering includes the exercise...

Agrify’s Stackable Cultivation Solutions Will Double Canopy for Prominent Multi-State Operator BILLERICA, Mass., April 06, 2022 (GLOBE NEWSWIRE) — Agrify Corporation (Nasdaq:AGFY) (“Agrify” or the “Company”), the most innovative provider of advanced cultivation and extraction solutions for the cannabis industry, today announced that it has signed an agreement (“the Agreement”) with Greenlight Cannabis (“Greenlight” www.greenlightdispensary.com) to provide premium grow solutions and related services for Greenlight’s cultivation facilities. With 28 locations and growing across 5 states, Greenlight is a prominent multi-state operator (“MSO”) in the United States and provides consumers with high-quality and unique medical cannabis experiences. Under the terms of the Agreement, Agrify will install its latest generation Vertical Farming...

Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, April 06, 2022 (GLOBE NEWSWIRE) — (TSX: LCS, LCS.PR.A) Brompton Lifeco Split Corp. (the “Company”) is pleased to announce that it has completed the previously announced treasury offering of class A shares and preferred shares (the “Class A Shares” and “Preferred Shares”, respectively) for aggregate gross proceeds of approximately $30 million. The Class A Shares and Preferred Shares will trade on the Toronto Stock Exchange (“TSX”) under the existing symbols LCS (Class A Shares) and LCS.PR.A (Preferred Shares). The Class A Shares were offered at a price of $6.70 per Class A Share for a distribution rate of 13.4% on the issue price, and the Preferred Shares were offered at a price of $10.05 per Preferred Share for a yield to maturity...

Orphazyme A/S in restructuringCompany announcement No. 19/2022        www.orphazyme.comCompany Registration No. 32266355Copenhagen, Denmark, April 6, 2022 – Orphazyme A/S in restructuring (ORPHA.CO; ORPH) (“Orphazyme” or the “Company”), a late-stage biopharmaceutical company, announces an update to the Company’s Financial Calendar for the remainder of 2022: Deadline for submission of shareholder proposals to Annual General MeetingNo later than six weeks prior to the Annual General Meeting 2022 Annual Report 2021April 29, 2022 Annual General Meeting 2022No later than 1 month after the completion of the ongoing in-court restructuring proceedings Interim Report First Half 2022August 25, 2022For additional information, please contact Orphazyme A/S in restructuring Anders Vadsholt, Chief Executive Officer and Chief Financial Officer        +45...

Selskabsmeddelelse Nr. 04/2022 Indeholder intern viden 6. April 2022 Erria A/S indgår endelig aftale om overtagelse af Cathay Seal Pte Ltd betinget af generalforsamlingens godkendelseog udstedelse af nye aktier til kurs DKK 3,70 pr. AktieErria A/S (”Selskabet”) har i dag indgået endelig aftale om overtagelse af det samlede ejerskab i Cathay Seal Pte Ltd betinget af Selskabets generalforsamlingsgodkendelse til at udstede nye aktier til sælgersiden. Handlen indebærer, at sælgerne af Cathay Seal tegner 1.621.622 nye aktier til kurs DKK 3,70 pr. aktie eller markedskursen på datoen for virksomhedsoverdragelsen, såfremt denne kurs er højere. Forudsat Selskabets generalforsamlingens godkendelse opnåes den 7. april 2022 under dets ordinære generalforsamling, forventer Selskabet, at virksomhedsoverdragelsen gennemføres inden en uge derefter. Selskabets...